Six clinical-grade exams done at home. Daily drop check-ins. A validated quality-of-life questionnaire. A doctor dashboard pre-sorted by risk. Built around the disease that loses sight in silence.
Patients don't notice peripheral-vision loss until it's too late. Once vision is lost, it doesn't come back. Yet office visits happen every six to twelve months, leaving long stretches of unmeasured drift between them.
Glaucoma is a chronic disease that doesn't deserve discrete care. The information that matters — pressure, adherence, symptoms, peripheral vision — drifts continuously. A tool that captures that drift continuously is the entire product.
Each module exists because the literature ties it directly to glaucoma progression or quality-of-life outcomes. Voice-guided, calibrated to the patient's screen and distance, recorded longitudinally.
Peripheral-vision damage is the diagnostic signature of glaucoma — and the patient never feels it until 30–40% of axons are gone. A 24-2 screening grid done at home, voice-guided, reveals scotomas months before the next office visit.
Heijl A et al · Acta Ophthalmologica · 2009Glaucoma usually preserves central acuity until late, which is why acuity tracking matters: it captures advanced disease, comorbid cataract or AMD, and post-surgical recovery. ETDRS-equivalent Snellen, calibrated to the screen, voice-guided answers.
Bailey IL & Lovie JE · AJOO · 1976 (chart standard)Glaucoma damages contrast perception well before visual-field defects show up — patients describe lights as dim, halos around streetlights, struggling at dusk. A Pelli-Robson-equivalent test caught this years before automated perimetry.
Hawkins AS et al · Ophthalmic Physiol Opt · 2003Chronic preservative-containing drops damage the ocular surface; the patient can't tolerate them, stops, and progression accelerates. Smartphone anterior-segment photos catch hyperaemia and blepharitis early so prescribing can switch to preservative-free before adherence collapses.
Baudouin C et al · Prog Retin Eye Res · 2010The validated NEI VFQ-25 captures the functional impact of vision loss before structural tests catch up — driving difficulty, falls, reading speed, social withdrawal. Required by FDA for clinical-trial endpoints. Filled out every 90 days inside the app.
Mangione CM et al · Arch Ophthalmol · 2001 (NEI VFQ-25)OHTS proved IOP-lowering halves five-year progression. Real-world adherence is ~50%. We schedule each drop, send daily check-ins via email, log every dose, and surface adherence trends to the doctor — turning the highest-leverage variable into a measurable one.
Kass MA et al · Arch Ophthalmol · 2002 (OHTS) · Friedman 2007
"In residency I watched the same pattern over and over: a patient comes back six months later, the visual field is worse, and we're reacting to damage that already happened. The data was always there — it was just trapped between visits. Glaucosim is the tool I wished I had."
Glaucosim was founded by an ophthalmologist with deep clinical training in glaucoma management, in collaboration with a software team building voice-first medical interfaces. The platform is being prepared for its first clinical pilot at the Hamilton Glaucoma Center, UC San Diego — one of the most respected glaucoma research programs in the world.
Patients get a quiet daily companion. Doctors get a longitudinal dashboard pre-sorted by risk. Both share the same data — only the lens changes.
The disease never sleeps. Neither does the loop. A few seconds a day is enough.
Open the dashboard, see who needs you today. Skip everything else.
One tap in the dashboard generates a tokenised invite link. The patient receives it by email — no public sign-up, no insurance gymnastics.
Glaucoma intake (diagnosis, medications, family history, current symptoms). Drops + schedule. Care plan created automatically with sensible defaults the doctor can override.
Patient logs drops + symptoms. Scheduled exams come up when due. Doctor sees the patient list re-prioritise as risk shifts.
First clinical pilot under preparation at the Hamilton Glaucoma Center, UC San Diego — one of the world's leading glaucoma research programs. IRB protocol in development; data captured under HIPAA-grade infrastructure with a signed BAA.
If you're a patient, ask your ophthalmologist to send you a Glaucosim invitation. There is no public sign-up — Glaucosim only works inside the doctor-patient relationship.